BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• XTL Biopharma Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Listing Requirements

  XTL Biopharma today announced that it has received notification from the NASDAQ that the Company has regained compliance with the minimum $2.5M stockholders’ equity requirement for continued listing on The Nasdaq Capital Market.

  December 6, 2017

   · 

  4 min read
• Business

  High Point Clinical Trials Center Appoints Clayton Dehn, M.S. as Vice President of Clinical Pharmacology Services

  Clayton will lead Clinical Pharmacology Services and act as the Subject Matter Expert in the Metabolic Sciences offering at HPCTC.

  December 6, 2017

   · 

  3 min read
• Drug Development

  ITM: Enrollment of First Gastroenteropancreatic-Neuroendocrine Tumor (GEP-NET) Patient in Europe for the COMPETE Phase III Clinical Trial With N.C.A.177Lu-Edotreotide (Solucin)

  The study will be conducted predominantly in Europe, North America, South Africa and Australia. The first patient to be enrolled and treated was in Australia.

  December 6, 2017

   · 

  2 min read
• Drug Development

  Madrigal’s MGL-3196 Achieves Primary Endpoint in Patients With Biopsy-Proven Non-alcoholic Steatohepatitis (NASH) in Phase II Clinical Trial

  In this trial, MGL-3196 demonstrated statistically significant results for the primary endpoint.

  December 6, 2017

   · 

  9 min read
• Data MATRIX Starts Projects in USA And Europe

  Data MATRIX team is about to start two new projects in the United States and Europe.

  December 6, 2017

   · 

  1 min read
• Business

  BioInvent and Transgene Collaborate on Next Generation Oncolytic Viruses Encoding an Anti-CTLA-4 Antibody to Treat Solid Tumors

  Transgene entered a collaboration to co-develop next generation oncolytic virus (OV) candidates encoding an anti-CTLA-4 antibody sequence - potentially with additional transgenes - capable of treating multiple solid tumors.

  December 6, 2017

   · 

  7 min read
• GW Pharmaceuticals Announces Proposed Public Offering of ADSs - Dec. 6, 2017

  The price for the offering has not yet been determined.

  December 6, 2017

   · 

  6 min read
• Pharm Country

  Children’s Hospital of Philadelphia Release: Brain Remaps Itself in Child With Double Hand Transplant

  The first child to undergo a successful hand transplant also is the first child in whom scientists have detected massive changes in how sensations from the hands are represented in the brain.

  December 6, 2017

   · 

  6 min read
• Synaffix Launches toxSYN, a New Platform of ADC Payloads

  Synaffix launch of a new platform of highly potent cytotoxic ADC payloads that will be integrated into its existing ADC platform.

  December 6, 2017

   · 

  3 min read
• Genetown

  Myomo Announces Full Exercise of Underwriter’s Over-Allotment Option in Follow-On Public Offering

  Myomo today announced that Roth Capital Partners, the underwriter of Myomo’s follow-on offering, exercised in full its option to purchase 626,250 shares of common stock.

  December 6, 2017

   · 

  3 min read